The latest evidence in the neuroscience of solvent misuse: An article written for service providers

Substance Use and Misuse

Volumn 46, Issue SUPPL. 1, 2011, Pages 62-67

  Cruz, Silvia L ^a,b,c  

^a Cinvestav Coapa   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c NONE   (Mexico)

Author keywords

acute effects; chronic effects; Inhalants; mechanisms of action; receptors; solvents; toluene

Indexed keywords

SOLVENT;

ADDICTION; CHEMICALLY INDUCED DISORDER; EVIDENCE BASED MEDICINE; HUMAN; MALE; NEUROLOGIC DISEASE; NEUROSCIENCE; REVIEW;

EVIDENCE-BASED MEDICINE; HUMANS; MALE; NERVOUS SYSTEM DISEASES; NEUROSCIENCES; SOLVENTS; SUBSTANCE-RELATED DISORDERS;

EID: 79957620444     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2011.580215     Document Type: Article

References (41)

1. Arlien-Søborg, P. (1992). Solvent neurotoxicity. Boca Raton, FL: CRC Press.
2. Bale, A. S., Tu, Y., Carpenter-Hyland, E. P., Chandler, L. J., & Woodward, J. J. (2005).Alterations in glutamatergic and gabaergic ion channel activity in hippocampal neurons following exposure to the abused inhalant toluene. Neuroscience, 130, 197-206. (Pubitemid 39550425)
3. Balster, R. L. (1991). Drug abuse potential evaluation in animals. British Journal of Addiction, 86, 1549-1558.
4. Balster, R. L. (1997). Inhalant abuse, a forgotten problem [Problems of Drug Dependence 1996: Proceedings of the 58th annual scientific meeting]. NIDA Research Monograph Series, 174, 3-8.
5. Balster, R. L. (1998). Neural basis of inhalant abuse. Drug and Alcohol Dependence, 51, 207-214. (Pubitemid 28353768)
6. Beckstead, M. J., Weiner, J. L., Eger, E. I., 2nd, Gong, D. H., & Mihic, S. J. (2000). Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Molecular Pharmacology, 57, 1199-1205. (Pubitemid 30354392)
7. Blokhina, E. A., Dravolina, O. A., Bespalov, A. Y., Balster, R. L., & Zvartau, E. E. (2004). Intravenous self-administration of abused solvents and anesthetics in mice. European Journal of Pharmacology, 485, 211-218. (Pubitemid 38134417)
8. Bowen, S. E. (2009). Time-course of the ethanol-like discriminative stimulus effects of abused inhalants in mice. Pharmacology Biochemistry and Behavior, 91, 345-350.
9. Bowen, S. E., Batis, J. C., Paez-Martinez, N., & Cruz, S. L. (2006). The last decade on solvent research in animal models of abuse: Mechanistic and behavioral effects. Neurotoxicology and Teratology, 28, 636-647. (Pubitemid 44829925)
10. Brouette, T., & Anton, R. (2001). Clinical review of inhalants. The American Journal on Addictions, 10, 79-94. (Pubitemid 32201735)
11. Cruz, S.L., & Ambrosio, E. (2009). Experimental models for the study of abused drugs. In L. L. Rocha-Arrieta, & V. Granados- Soto (Eds.), Models of neuropharmacology (pp. 229-240). Trivandrum: Transworld Research Network.
12. Cruz, S. L., Balster, R. L., & Woodward, J. J. (2000). Effects of volatile solvents on recombinant N-methyl-D-aspartate receptors expressed in Xenopus oocytes. British Journal of Pharmacology, 131, 1303-1308.
13. Cruz, S. L., & Bowen, S. E. (2008). Inhalant abuse. In M. Méndez Ubach, & R. Mondragón-Ceballos (Eds.), Neural mechanisms of action of drugs of abuse and natural reinforcers (pp. 61-87). Trivandrum: Research Signpost.
14. Cruz, S. L., Mirshahi, T., Thomas, B., Balster, R. L., &Woodward, J. J. (1998). Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics, 286, 334-340. (Pubitemid 28318008)
15. Cruz, S. L., Orta-Salazar, G., Gauthereau, M. Y., Millan-Perez Peña, L.,&Salinas-Stefanón, E. M. (2003). Inhibition of cardiac sodium currents by toluene exposure. British Journal of Pharmacology, 140, 653-660. (Pubitemid 37386429)
16. Dinwiddie, S. H. (1994). Abuse of inhalants: A review. Addiction, 89, 925-939. (Pubitemid 24247657)
17. Eisenberg, D. P. (2003). Neurotoxicity and mechanisms of toluene abuse. The Einstein Quarterly Journal of Biology and Medicine, 19, 150-159.
18. Evans, E. B., & Balster, R. L. (1991). CNS depressant effects of volatile organic solvents. Neuroscience and Biobehavioral Review, 15, 233-241.
19. Filley, C. M., Halliday, W., & Kleinschmidt-DeMasters, B. K. (2004). The effects of toluene on the central nervous system. Journal of Neuropathology and Experimental Neurology, 63, 1-12. (Pubitemid 38030228)
20. Flanagan, R. J., & Ives, R. J. (1994). Volatile substance abuse. Bulletin on Narcotics, 46, 49-78.
21. Freedenthal, S., Vaughn, M. G., Jenson, J. M., & Howard, M. O. (2007). Inhalant use and suicidality among incarcerated youth. Drug and Alcohol Dependence, 90, 81-88. (Pubitemid 46935376)
22. Koob, G. F., & LeMoal, M. (2006). Neurobiology of addiction. San Diego, CA: Academic Press.
23. Krasowski, M. D. (2000). Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels. Neuropharmacology, 39, 1168-1183. (Pubitemid 30173182)
24. Lobo, I. A. (2004). Inhalants. Drugs: The straight facts. NewYork: Chelsea House.
25. Lorenc, J. D. (2003). Inhalant abuse in the pediatric population: A persistent challenge. Current Opinion in Pediatrics, 15, 204-209. (Pubitemid 36337834)
26. Lubman, D. I., Hides, L., & Yücel, M. (2006). Inhalant misuse in youth: Time for a coordinated response. The Medical Journal of Australia, 185, 327-330. (Pubitemid 44515436)
27. MacIver, M. B. (2009). Abused inhalants enhance GABA-mediated synaptic inhibition. Neuropsychopharmacology, 34, 2296-2304.
28. MacLean, S. (2008). Volatile bodies: Stories of corporeal pleasure and damage in marginalised young people's drug use. International Journal of Drug Policy, 19, 375-383.
29. Medina-Mora, M. E., & Real, T. (2008). Epidemiology of inhalant use. Current Opinion in Psychiatry, 21, 247-251. (Pubitemid 351489343)
30. Ridenour, T. A. (2005). Inhalants: Not to be taken lightly anymore. Current Opinion in Psychiatry, 18, 243-247. (Pubitemid 40586106)
31. Ridenour, T. A., Bray, B. C., & Cottler, L. B. (2007). Reliability of use, abuse, and dependence of four types of inhalants in adolescents and young adults. Drug and Alcohol Dependence, 91, 40-49. (Pubitemid 47393602)
32. Riegel, A. C., & French, E. D. (1999). Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacology Biochemistry and Behavior, 62, 399-402. (Pubitemid 29117179)
33. Sharp, C. W., Rosenberg, N., & Beauvais, F. (2008). Substance abuse: Inhalant-related disorders. In A. Tasman, J. Kay, J. A. Lieberman, M. B. First, & M. Maj (Eds.), Psychiatry (3rd ed., pp. 1127-1148). New York, NY: John Wiley.
34. Shelton, K. L. (2009). Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: Comparison to other hydrocarbon vapors and volatile anesthetics. Psychopharmacology, 203, 431-440.
35. Snyder, R. (2002). Benzene and leukemia. Critical Reviews in Toxicology, 32, 155-210. (Pubitemid 34615404)
36. Weber, L. W., Boll, M., & Stampfl, A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: Carbon tetrachloride as a toxicological model. Critical Reviews in Toxicology, 33, 105-136. (Pubitemid 36432872)
37. White, R. F., & Proctor, S. P. (1997). Solvents and neurotoxicity. The Lancet, 349, 1239-1243. (Pubitemid 27190057)
38. Williams, J. F., Storck, M.; The Committee on Substance Abuse (Committee on Native American Child Health). (2007). Inhalant abuse. American Academy of Pediatrics, 119, 1009-1017. (Pubitemid 46715675)
39. Willner, P. (1995). Animal models of depression: Validity and applications. Advances in Biochemistry and Psychopharmacology, 49, 19-41.
40. Wise, R. A., & Gardner, E. L. (2004). Animal models of addiction. In D. S. Charney, & E. J. Nestler (Eds.), Neurobiology ofMental Illness (2nd ed., pp. 683-697). New York: Oxford University Press.
41. Wu, L. T., & Howard, M. O. (2007). Psychiatric disorders in inhalant users: Results from the National Epidemiologic Survey on alcohol and related conditions. Drug and Alcohol Dependence, 88, 146-155. (Pubitemid 46482821)